We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MEDP market cap is 12.03B. The company's latest EPS is USD 9.1943 and P/E is 42.51.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 383.74M | 394.1M | 434.07M | 460.87M | 492.5M |
Operating Income | -149.1M | 76.43M | 86.2M | 78.39M | -245.93M |
Net Income | 66.03M | 68.67M | 72.89M | 61.07M | 70.55M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 860.97M | 925.93M | 1.14B | 1.46B | 1.89B |
Operating Income | 127.26M | 167.04M | 198.62M | 278.7M | 336.83M |
Net Income | 100.44M | 145.38M | 181.85M | 245.37M | 282.81M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.33B | 1.35B | 1.4B | 1.41B | 1.49B |
Total Liabilities | 978.54M | 966.11M | 1.05B | 1.02B | 1.02B |
Total Equity | 349.89M | 386.39M | 347.26M | 391.06M | 470.91M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.14B | 1.39B | 1.66B | 1.35B | 1.66B |
Total Liabilities | 416.79M | 584.9M | 707.01M | 966.11M | 1.1B |
Total Equity | 726.28M | 805.78M | 952.93M | 386.39M | 558.95M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 251.37M | 388.05M | 80.08M | 162.59M | 276.98M |
Investing | -29.52M | -38.74M | -9.5M | -17.97M | -26.63M |
Financing | -644.65M | -775.78M | -52.68M | -134.89M | -184.17M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 201.87M | 258.68M | 263.33M | 388.05M | 433.37M |
Investing | -19.14M | -31.21M | -31.36M | -38.74M | -34.63M |
Financing | -73.92M | -82.28M | -44.45M | -775.78M | -182.64M |
Market Cap | 12.03B |
Price to Earnings Ratio | 42.51 |
Price to Sales Ratio | 6.37 |
Price to Cash Ratio | 48.98 |
Price to Book Ratio | 21.51 |
Dividend Yield | - |
Shares Outstanding | 30.76M |
Average Volume (1 week) | 245.41k |
Average Volume (1 Month) | 255k |
52 Week Change | 89.97% |
52 Week High | 421.00 |
52 Week Low | 197.39 |
Spread (Intraday) | 282.42 (45.01%) |
Company Name | Medpace Holdings Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.medpace.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions